(Q48881749)

16 February 2018

title

Curcumin Ameliorates Memory Decline via Inhibiting BACE1 Expression and β-Amyloid Pathology in 5×FAD Transgenic Mice. (English)

1 reference

16 February 2018

0 references

Kunmu Zheng

1

1 reference

16 February 2018

Xiaoman Dai

2

1 reference

16 February 2018

Nai'an Xiao

3

1 reference

16 February 2018

Xilin Wu

4

1 reference

16 February 2018

Zhen Wei

5

1 reference

16 February 2018

Wenting Fang

6

1 reference

16 February 2018

Yuangui Zhu

7

1 reference

16 February 2018

Jing Zhang

8

1 reference

16 February 2018

Xiaochun Chen

9

1 reference

16 February 2018

publication date

24 February 2016

1 reference

16 February 2018

published in

Molecular Neurobiology

1 reference

16 February 2018

volume

54

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

page(s)

1967-1977

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/s12035-016-9802-9

exact match

0 references

cites work

Alzheimer's disease and Abeta toxicity: from top to bottom

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

APP processing in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Insulin-degrading enzyme sorting in exosomes: a secretory pathway for a key brain amyloid-beta degrading protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Neprilysin and amyloid beta peptide degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Stability of curcumin in buffer solutions and characterization of its degradation products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Pharmacology of Curcuma longa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Incidence of Alzheimer's disease in a rural community in India: the Indo-US study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Synaptic plasticity, memory and the hippocampus: a neural network approach to causality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Synaptic Signaling in Learning and Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Synaptophysin is required for synaptobrevin retrieval during synaptic vesicle endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Abeta(1-42) reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: a quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Aβ oligomers inhibit synapse remodelling necessary for memory consolidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Aβ oligomer-induced synapse degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

APP processing, A beta-amyloidogenesis, and the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

APP processing and the APP-KPI domain involvement in the amyloid cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

BACE1 is the major beta-secretase for generation of Abeta peptides by neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

β-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Transcriptional regulation of BACE1 by NFAT3 leads to enhanced amyloidogenic processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Metabolic stress modulates Alzheimer's β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Curcumin inhibits the AKT/NF-κB signaling via CpG demethylation of the promoter and restoration of NEP in the N2a cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Curcumin suppresses T cell activation by blocking Ca2+ mobilization and nuclear factor of activated T cells (NFAT) activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Curcumin protects neurons against oxygen-glucose deprivation/reoxygenation-induced injury through activation of peroxisome proliferator-activated receptor-γ function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNF alpha and Notch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Curcumin Inhibits TLR2/4-NF-κB Signaling Pathway and Attenuates Brain Damage in Permanent Focal Cerebral Ischemia in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Coordinated Expression of β-Amyloid Precursor Protein and the Putative β-Secretase BACE and α-Secretase ADAM10 in Mouse and Human Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9802-9

Alzheimer's disease-related synapse loss in the cingulate cortex

21 January 2018

1 reference

12 December 2020

Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa

1 reference

12 December 2020

Alzheimer's disease: genes, proteins, and therapy

1 reference

12 December 2020

[Effect of curcumin on expression of Abeta42 and Abeta-degrading enzyme NEP in APPswe/PS1dE9 double transgenic mice].

1 reference

12 December 2020

10.1007/S12035-016-9802-9

Identifiers

DOI

1 reference

16 February 2018

release_shqpgxrml5gqflaxvt5ebibvoq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/shqpgxrml5gqflaxvt5ebibvoq

24 November 2022

mapped directly with Wikidata item

PubMed ID

26910813

1 reference

16 February 2018